Back to Search
Start Over
Cost-effectiveness of
- Source :
- The European respiratory journal. 51(3)
- Publication Year :
- 2017
- Subjects :
- Adult
Aged, 80 and over
Male
Lung Neoplasms
Cost-Benefit Analysis
DNA Mutational Analysis
Decision Making
Middle Aged
ErbB Receptors
Proto-Oncogene Proteins p21(ras)
Carcinoma, Non-Small-Cell Lung
Mutation
Pulmonary Medicine
Humans
Anaplastic Lymphoma Kinase
Female
France
Genetic Testing
Longitudinal Studies
Biomarkers
Aged
Subjects
Details
- ISSN :
- 13993003
- Volume :
- 51
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- The European respiratory journal
- Accession number :
- edsair.pmid..........2e7923530fec6b24d667fd6fba24cb51